1 week ago
49
A once-daily pill is giving late-stage pancreatic cancer patients something the disease has rarely offered: more time.
CLEVELAND — A new pancreatic cancer drug called daraxonrasib has been showing striking results in clinical trials. Now it's available to patients at University Hospitals Seidman Cancer Center, the first health system in Northeast Ohio to offer it.
A breakthrough decades in the making
Pancreatic cancer has long b...
